SSG Advises ICON Aircraft, Inc. in the Sale of Substantially All Assets to an Affiliate of Dürkopp Adler GmbH
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to ICON Aircraft, Inc. (“ICON” or the “Company”) in the sale of substantially all assets to an affiliate of Dürkopp Adler GmbH (“DA”). The sale was effectuated through a….
READ MORESSG Advises the Chapter 7 Trustee of Gelesis Holdings Inc. in the Sale of Substantially All Assets to an Affiliate of Theras Group S.r.l.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to George L. Miller, the Chapter 7 Trustee (“Trustee”) of Gelesis Holdings Inc. and certain affiliates (collectively, “Gelesis” or the “Company”), in the sale of substantially all assets to….
READ MORESSG Advises Eiger BioPharmaceuticals, Inc. in the Sale of Avexitide Program Assets to Amylyx Pharmaceuticals
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Eiger BioPharmaceuticals, Inc. (“Eiger” or the “Company”) in the sale of Avexitide and its related clinical assets to Amylyx Pharmaceuticals, Inc. The sale was effectuated through a Chapter….
READ MORESSG Advises CPL in the Sale to Aterian Investment Partners
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Contract Pharmaceuticals Limited Canada and its affiliates (“CPL” or the “Company”) in its restructuring and sale to Aterian Investment Partners via a Reverse Vesting Order (“RVO”). The sale….
READ MORESSG Advises Eiger BioPharmaceuticals, Inc. in the Sale of Zokinvy® Program Assets to Sentynl Therapeutics, Inc.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Eiger BioPharmaceuticals, Inc. (“Eiger” or the “Company”) in the sale of substantially all of its assets related to the FDA-approved drug Zokinvy®, to Sentynl Therapeutics, Inc. The sale….
READ MORE